Fischer Medical Ventures’ Subsidiary Wins Province-Wide Digital Healthcare Project in the Philippines
Fischer Medical Ventures Limited (NSE: FISCHER, BSE: 524743) has announced that its step-down subsidiary, Time Medical Philippines (TM-P), has been awarded a province-wide digital healthcare project in Catanduanes Province, Philippines.
The project will deploy an integrated digital healthcare solution combining Health Kiosks with the PhilHealth-accredited FlynnCare Clinic Management System (CMS). The company described the project as the first province-wide implementation of this integrated healthcare model in the Philippines.
Fischer Medical Ventures Digital Healthcare Project
Under the project, Time Medical Philippines will work with its digital health partner, FlynnCare, to deploy an integrated healthcare platform across Catanduanes Province.
The solution combines:
- Health Kiosks
- Digital clinical workflows
- PhilHealth-accredited FlynnCare Clinic Management System
- Community-level health screening
- Connected diagnostics
- Teleconsultation
- Structured patient information
The objective is to connect community-level healthcare delivery with digital clinical systems and improve access to healthcare services, particularly in municipalities and barangays where healthcare and diagnostic infrastructure may be limited.
First Province-Wide Integrated Digital Healthcare Model
The Catanduanes project represents an important milestone for Fischer Medical Ventures and Time Medical Philippines because it is described as the first province-wide implementation of this integrated healthcare model in the Philippines.
According to the company, the project supports the digitalization of the Philippines’ Universal Health Care programme by connecting frontline healthcare delivery with structured digital workflows and patient information.
The company believes the Catanduanes rollout can provide a model for broader deployment of digitally connected healthcare across other municipalities and provinces.
Potential for Expansion Across Philippines and Other Markets
Fischer Medical Ventures said Time Medical Philippines and FlynnCare are exploring similar large-scale opportunities across the Philippines and other markets with comparable healthcare requirements.
The group’s capabilities include:
- Health Kiosks
- AI-powered screening
- Preventive healthcare
- TeleRadiology
- Tele-Diagnosis
- Digital healthcare platforms
- Connected healthcare pathways
The company said these capabilities could support scalable deployments, long-term technology support and potential recurring revenue models across multiple markets.
Importantly, the announcement does not disclose the contract value, revenue contribution, project duration or profitability impact of the Catanduanes project.
Management Commentary
Ravindran Govindan, Chairman and Managing Director of Fischer Medical Ventures, said the company and Time Medical Philippines remain committed to transforming healthcare delivery through integrated medical technology and digital health solutions.
The company said the Catanduanes project will integrate Health Kiosks with the PhilHealth-accredited FlynnCare CMS to provide municipal and barangay health teams with connected screening, structured clinical workflows, teleconsultation capabilities and access to patient information.
Management also highlighted the potential role of digitally connected healthcare in improving access, strengthening coordination and reducing delays in healthcare delivery.
Fischer Medical Ventures’ Digital Healthcare Business
Time Medical Philippines is a subsidiary of Time Medical International Ventures (India) Private Limited, which is wholly owned by Fischer Medical Ventures.
The company operates in areas including medical imaging, diagnostics, preventive healthcare, digital health and treatment solutions, with a focus on bringing accessible healthcare technologies to the Philippines.
FlynnCare is described as a Chennai-based HealthTech company focused on AI-powered screening and early detection.
Its eHAP ecosystem integrates diagnostic tools covering areas such as vitals, cardiovascular, lung, mental, eye, oral, women’s and cancer health, along with palliative care support.
Point to consider
For investors, the key development is the expansion of Fischer Medical Ventures’ digital healthcare operations into a province-wide healthcare deployment in the Philippines.
The project could provide the company with an opportunity to demonstrate its integrated digital healthcare model at scale. If successfully implemented, the Catanduanes rollout could potentially support the company’s efforts to pursue similar projects in other provinces and international markets.
However, investors should note that the current announcement does not provide financial details such as the order value, expected revenue, margins, or earnings contribution from the project. Therefore, the financial impact cannot be quantified based on this announcement alone.
Key Points
The important developments to monitor going forward include:
- Implementation of the Catanduanes project and its operational progress.
- Potential replication of the model across other Philippine provinces.
- New contracts involving Health Kiosks and digital healthcare solutions.
- Expansion of AI-enabled screening and diagnostics.
- Development of recurring revenue opportunities from digital healthcare platforms.
- Expansion into other international markets with similar healthcare requirements.
Summary
Fischer Medical Ventures’ subsidiary Time Medical Philippines has secured a significant digital healthcare project covering Catanduanes Province in the Philippines.
The integration of Health Kiosks with FlynnCare’s PhilHealth-accredited Clinic Management System is intended to connect community-level screening, diagnostics, clinical workflows and teleconsultation.
While the company has not disclosed the financial value of the project, the province-wide deployment could serve as an important reference project for Fischer Medical Ventures as it seeks to expand its digital healthcare solutions across the Philippines and other international markets.
Disclaimer
This article is based on the company’s press release dated August 24, 2026. The information is provided for educational and informational purposes only and should not be considered investment advice. The company’s release contains forward-looking statements that are subject to risks and uncertainties, including government actions, political and economic developments, technological risks, regulatory changes and other factors. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.